查看購物車
  • English
  • Japanese
  • Korean
2026-2030年全球連續血糖監測（CGM）市場
市場調查報告書
商品編碼
2109618

2026-2030年全球連續血糖監測（CGM）市場

Global Continuous Glucose Monitoring (CGM) Market 2026-2030
出版日期: | 出版商: TechNavio | 英文 291 Pages | 訂單完成後即時交付

價格
簡介目錄

全球連續血糖監測（CGM）市場預計將從 2025 年到 2030 年成長至 112.465 億美元，預測期內複合年成長率為 13.0%。

本報告對全球連續血糖監測 (CGM) 市場進行了全面分析，包括市場規模和預測、趨勢、成長要素、挑戰以及對約 25 家公司的供應商分析。

本報告對當前市場狀況、最新趨勢和促進因素以及整體市場環境進行了最新分析。推動市場成長的因素包括：自動化胰島素輸注技術的日益普及、適應症範圍擴大以涵蓋更多目標患者群體以及遠端患者監護系統的整合。

本研究客觀地結合了一手和二手訊息，包括來自主要行業相關人員的信息。報告內容涵蓋主要公司分析、全面的市場規模資料、細分市場數據及區域分析，以及供應商格局。報告包含歷史數據和預測數據。

市場範圍
基準年 2025
年末 2030
調查期 2026-2030
成長勢頭 加速度
2026 年同比比較 12.9%
複合年成長率 13%
增量 112.465億美元

本研究指出，未來幾年，非侵入式感測技術的應用將成為全球連續血糖監測（CGM）市場成長的主要驅動力之一。此外，與智慧生活方式生態系統的融合以及慢性糖尿病盛行率的不斷上升，預計也將帶來顯著的市場需求。

目錄

第1章：執行摘要

第2章 Technavio 分析

  • 分析定價、生命週期、顧客購買籃子、採用率和購買標準。
  • 輸入的重要性及差異化因素
  • 干擾因素
  • 促進因素和挑戰的影響

第3章 市場狀況

  • 市場生態系統
  • 市場特徵
  • 價值鏈分析

第4章 市場規模

  • 市場的定義
  • 市場區隔分析
  • 2025年市場規模
  • 市場展望，2025-2030年

第5章 市場規模與表現

  • 2020-2024年全球連續血糖監測（CGM）市場
  • 基於組件的細分市場分析，2020-2024 年
  • 2020年至2024年最終用戶細分市場分析
  • 2020-2024年年齡層細分分析
  • 區域區隔市場分析，2020-2024 年
  • 2020-2024年各國細分市場分析

第6章 定性分析

  • 人工智慧的影響：全球連續血糖監測（CGM）市場
  • 地緣政治衝突對全球連續血糖監測（CGM）市場的影響。

第7章：五力分析

第8章 市場區隔：按組件

  • 比較：按組件
  • 感應器
  • 發送器
  • 接收器
  • 市場機會：按組件分類

第9章 市場區隔：依最終用戶分類

  • 比較：按最終用戶
  • 居家照護
  • 醫院
  • 其他
  • 市場機會：依最終用戶分類

第10章 市場區隔：依年齡層

  • 比較：依年齡層
  • 成人
  • 兒童
  • 市場機會：依年齡層別分類

第11章 客戶情況

第12章 區域情勢

  • 區域分類
  • 區域比較
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 荷蘭
    • 西班牙
  • 亞洲
    • 中國
    • 印度
    • 日本
    • 韓國
    • 泰國
    • 印尼
  • 世界其他地區（RoW）
    • 巴西
    • 沙烏地阿拉伯
    • 阿根廷
    • UAE
    • 南非
    • 哥倫比亞
    • 土耳其
    • 以色列
  • 市場機會：按地區分類

第13章 促進因素、挑戰與機遇

  • 市場促進因素
  • 市場挑戰
  • 促進因素和挑戰的影響
  • 市場機遇

第14章 競爭格局

  • 概述
  • 競爭格局
  • 混亂局面
  • 產業風險

第15章 競爭分析

  • 公司簡介
  • 公司排名指標
  • 企業市場定位
  • Abbott Laboratories
  • Eoflow Co. Ltd.
  • F. Hoffmann La Roche Ltd.
  • Glooko Inc.
  • I SENS Inc.
  • Insulet Corp.
  • LifeScan IP Holdings LLC
  • Medtronic Plc
  • MicroTech MD
  • Signos
  • Sinocare Inc.
  • Tenovi
  • Terumo Corp.
  • XMYL CGM
  • Yuwell PoCTech

第16章附錄

簡介目錄
Product Code: IRTNTR74778

The global continuous glucose monitoring (CGM) market is forecasted to grow by USD 11246.5 mn during 2025-2030, accelerating at a CAGR of 13.0% during the forecast period. The report on the global continuous glucose monitoring (CGM) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing adoption of automated insulin delivery, expanded clinical indications for patient populations, integration of remote patient monitoring systems.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Market Scope
Base Year2025
End Year2030
Series Year2026-2030
Growth MomentumAccelerate
YOY 202612.9%
CAGR13%
Incremental Value$11246.5 mn

Technavio's global continuous glucose monitoring (CGM) market is segmented as below:

By Component

  • Sensors
  • Transmitters
  • Receivers

By End-User

  • Home care
  • Hospitals
  • Others

By Age Group

  • Adult
  • Paediatric

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • The Netherlands
    • Spain
  • Asia
  • Rest of World (ROW)
  • Rest of World (ROW)

This study identifies the adoption of non-invasive sensing technologies as one of the prime reasons driving the global continuous glucose monitoring (CGM) market growth during the next few years. Also, convergence with intelligent lifestyle ecosystems and increasing prevalence of chronic diabetes will lead to sizable demand in the market.

The report on the global continuous glucose monitoring (CGM) market covers the following areas:

  • Global continuous glucose monitoring (CGM) market sizing
  • Global continuous glucose monitoring (CGM) market forecast
  • Global continuous glucose monitoring (CGM) market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global continuous glucose monitoring (CGM) market vendors that include Abbott Laboratories, Biolinq Inc, Eoflow Co. Ltd., F. Hoffmann La Roche Ltd., Glooko Inc., GlucoRx CGM, GlySens Inc., I SENS Inc., Insulet Corp., LifeScan IP Holdings LLC, Medtronic Plc, MicroTech MD, Senseonics Holdings Inc., SiBionics, Signos, Sinocare Inc., Tenovi, Terumo Corp., XMYL CGM, Yuwell PoCTech. Also, the global continuous glucose monitoring (CGM) market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market by Geography
    • Executive Summary - Chart on Market Segmentation by Component
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Age Group
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
  • 2.3 Factors of disruption
  • 2.4 Impact of drivers and challenges

3 Market Landscape

  • 3.1 Market ecosystem
  • 3.2 Market characteristics
  • 3.3 Value chain analysis

4 Market Sizing

  • 4.1 Market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2025
  • 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

  • 5.1 Global Continuous Glucose Monitoring (CGM) Market 2020 - 2024
    • Historic Market Size - Data Table on Global Continuous Glucose Monitoring (CGM) Market 2020 - 2024 ($ million)
  • 5.2 Component segment analysis 2020 - 2024
    • Historic Market Size - Component Segment 2020 - 2024 ($ million)
  • 5.3 End-user segment analysis 2020 - 2024
    • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
  • 5.4 Age Group segment analysis 2020 - 2024
    • Historic Market Size - Age Group Segment 2020 - 2024 ($ million)
  • 5.5 Geography segment analysis 2020 - 2024
    • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
  • 5.6 Country segment analysis 2020 - 2024
    • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Continuous Glucose Monitoring (CGM) Market
  • 6.2 Impact of geopolitical conflicts on Global Continuous Glucose Monitoring (CGM) Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2025 and 2030
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2025 and 2030
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2025 and 2030
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2025 and 2030
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2025 and 2030
  • 7.7 Market condition

8 Market Segmentation by Component

  • 8.1 Market segments
  • 8.2 Comparison by Component
  • 8.3 Sensors - Market size and forecast 2025-2030
  • 8.4 Transmitters - Market size and forecast 2025-2030
  • 8.5 Receivers - Market size and forecast 2025-2030
  • 8.6 Market opportunity by Component
    • Market opportunity by Component ($ million)

9 Market Segmentation by End-user

  • 9.1 Market segments
  • 9.2 Comparison by End-user
  • 9.3 Home care - Market size and forecast 2025-2030
  • 9.4 Hospitals - Market size and forecast 2025-2030
  • 9.5 Others - Market size and forecast 2025-2030
  • 9.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)

10 Market Segmentation by Age Group

  • 10.1 Market segments
  • 10.2 Comparison by Age Group
  • 10.3 Adult - Market size and forecast 2025-2030
  • 10.4 Paediatric - Market size and forecast 2025-2030
  • 10.5 Market opportunity by Age Group
    • Market opportunity by Age Group ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
  • 12.2 Geographic comparison
  • 12.3 North America - Market size and forecast 2025-2030
    • 12.3.1 US - Market size and forecast 2025-2030
    • 12.3.2 Canada - Market size and forecast 2025-2030
    • 12.3.3 Mexico - Market size and forecast 2025-2030
  • 12.4 Europe - Market size and forecast 2025-2030
    • 12.4.1 Germany - Market size and forecast 2025-2030
    • 12.4.2 UK - Market size and forecast 2025-2030
    • 12.4.3 France - Market size and forecast 2025-2030
    • 12.4.4 Italy - Market size and forecast 2025-2030
    • 12.4.5 The Netherlands - Market size and forecast 2025-2030
    • 12.4.6 Spain - Market size and forecast 2025-2030
  • 12.5 Asia - Market size and forecast 2025-2030
    • 12.5.1 China - Market size and forecast 2025-2030
    • 12.5.2 India - Market size and forecast 2025-2030
    • 12.5.3 Japan - Market size and forecast 2025-2030
    • 12.5.4 South Korea - Market size and forecast 2025-2030
    • 12.5.5 Thailand - Market size and forecast 2025-2030
    • 12.5.6 Indonesia - Market size and forecast 2025-2030
  • 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
    • 12.6.1 Brazil - Market size and forecast 2025-2030
    • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
    • 12.6.3 Argentina - Market size and forecast 2025-2030
    • 12.6.4 UAE - Market size and forecast 2025-2030
    • 12.6.5 South Africa - Market size and forecast 2025-2030
    • 12.6.6 Colombia - Market size and forecast 2025-2030
    • 12.6.7 Turkey - Market size and forecast 2025-2030
    • 12.6.8 Israel - Market size and forecast 2025-2030
  • 12.7 Market opportunity by geography
    • Market opportunity by geography ($ million)
    • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

  • 13.1 Market drivers
    • Increasing adoption of automated insulin delivery
    • Expanded clinical indications for patient populations
    • Integration of remote patient monitoring systems
  • 13.2 Market challenges
    • High costs impede global market accessibility
    • Regulatory complexity slows global technological innovation
    • Technical obstacles in data privacy integration
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2025 and 2030
  • 13.4 Market opportunities
    • Adoption of non-invasive sensing technologies
    • Convergence with intelligent lifestyle ecosystems
    • Increasing prevalence of chronic diabetes

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Abbott Laboratories
    • Abbott Laboratories - Overview
    • Abbott Laboratories - Business segments
    • Abbott Laboratories - Key news
    • Abbott Laboratories - Key offerings
    • Abbott Laboratories - Segment focus
    • SWOT
  • 15.5 Eoflow Co. Ltd.
    • Eoflow Co. Ltd. - Overview
    • Eoflow Co. Ltd. - Product / Service
    • Eoflow Co. Ltd. - Key offerings
    • SWOT
  • 15.6 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 15.7 Glooko Inc.
    • Glooko Inc. - Overview
    • Glooko Inc. - Product / Service
    • Glooko Inc. - Key offerings
    • SWOT
  • 15.8 I SENS Inc.
    • I SENS Inc. - Overview
    • I SENS Inc. - Product / Service
    • I SENS Inc. - Key offerings
    • SWOT
  • 15.9 Insulet Corp.
    • Insulet Corp. - Overview
    • Insulet Corp. - Product / Service
    • Insulet Corp. - Key news
    • Insulet Corp. - Key offerings
    • SWOT
  • 15.10 LifeScan IP Holdings LLC
    • LifeScan IP Holdings LLC - Overview
    • LifeScan IP Holdings LLC - Product / Service
    • LifeScan IP Holdings LLC - Key offerings
    • SWOT
  • 15.11 Medtronic Plc
    • Medtronic Plc - Overview
    • Medtronic Plc - Business segments
    • Medtronic Plc - Key news
    • Medtronic Plc - Key offerings
    • Medtronic Plc - Segment focus
    • SWOT
  • 15.12 MicroTech MD
    • MicroTech MD - Overview
    • MicroTech MD - Product / Service
    • MicroTech MD - Key offerings
    • SWOT
  • 15.13 Signos
    • Signos - Overview
    • Signos - Product / Service
    • Signos - Key offerings
    • SWOT
  • 15.14 Sinocare Inc.
    • Sinocare Inc. - Overview
    • Sinocare Inc. - Product / Service
    • Sinocare Inc. - Key offerings
    • SWOT
  • 15.15 Tenovi
    • Tenovi - Overview
    • Tenovi - Product / Service
    • Tenovi - Key offerings
    • SWOT
  • 15.16 Terumo Corp.
    • Terumo Corp. - Overview
    • Terumo Corp. - Business segments
    • Terumo Corp. - Key news
    • Terumo Corp. - Key offerings
    • Terumo Corp. - Segment focus
    • SWOT
  • 15.17 XMYL CGM
    • XMYL CGM - Overview
    • XMYL CGM - Product / Service
    • XMYL CGM - Key offerings
    • SWOT
  • 15.18 Yuwell PoCTech
    • Yuwell PoCTech - Overview
    • Yuwell PoCTech - Product / Service
    • Yuwell PoCTech - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
    • Market definition
    • Objectives
    • Notes and caveats
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations